| 000 | 01715 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513054047.0 | ||
| 264 | 0 | _c19950113 | |
| 008 | 199501s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00051a008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMinor, D L | |
| 245 | 0 | 0 |
_aSynthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cDec 1994 |
||
| 300 |
_a4317-28 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xmetabolism |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry, Physical |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aCorpus Striatum _xmetabolism |
| 650 | 0 | 4 | _aElectrochemistry |
| 650 | 0 | 4 |
_aIsoquinolines _xchemical synthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 |
_aQuinolizines _xchemical synthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aWyrick, S D | |
| 700 | 1 | _aCharifson, P S | |
| 700 | 1 | _aWatts, V J | |
| 700 | 1 | _aNichols, D E | |
| 700 | 1 | _aMailman, R B | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 37 _gno. 25 _gp. 4317-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00051a008 _zAvailable from publisher's website |
| 999 |
_c7995872 _d7995872 |
||